
Baili Biopharma
百力司康
Baili Biopharma
Biotech/Healthcare
Bliss Biopharmaceutical is a developer of targeted oncology and immunotherapy drugs, focused on the R&D, commercialization, and manufacturing of biopharmaceuticals for targeted cancer therapy and immunotherapy. Its pipeline includes antibody-drug conjugates developed in partnership with Morphotek…
Latest round: Series B Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.